Eton Pharmaceuticals Licenses U.S. Rights To Rare Disease Product Candidate ASN-001 From Auson Pharmaceuticals For Treatment Of Proliferating Superficial Infantile Hemangiomas

뉴스 본문을 불러오고 있어요.

Eton Pharmaceuticals Licenses U.S. Rights To Rare Disease Product Candidate ASN-001 From Auson Pharmaceuticals For Treatment Of Proliferating Superficial Infantile Hemangiomas | 웨이프 WAPE

Eton Pharmaceuticals Licenses U.S. Rights To Rare Disease Product Candidate ASN-001 From Auson Pharmaceuticals For Treatment Of Proliferating Superficial Infantile Hemangiomas

기사 요약

관련 종목

댓글 —